Zoekresultaten - 14 results
Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services
underscreened women urine self-sampling vaginal self-sampling Abstract: Self-sampling may improve participation in cervical cancer secondary prevention programs by women who do not respond or respond irregularly ...
The European response to the WHO call cervical cancer as a public health problem
Issue 2 (2021) Keywords: cervical cancer screening COVID-19 elimination of cervical cancer Europe HPV vaccination WHO Abstract: The age‐standardised incidence of cervical cancer in Europe varies widely ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
applied on self-collected samples, a strategy that might be used to reach underscreened populations. In May, 2018, the WHO Director General launched a call to eliminate cervical cancer by vaccinating at ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
can be triaged accurately with a high-risk human papillomavirus (hrHPV) test to identify those who need a referral. However, the triage of low-grade squamous intraepithelial lesion (LSIL) with hrHPV ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
this short summary deals with the triage, treatment and follow-up care of cervical dysplasia. With regard to those women who do not participate in screening, the guideline authors recommend sending out ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
review: study population included women who were irregularly or never screened; women in the self sampling arm (intervention arm) were invited to collect a self sample for hrHPV testing; women in the ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
adenocarcinoma in situ associated with HPV16 /18 infection in young women who were not initially infected with hrHPV or HPV16 /18. Vaccine efficacy was lower when all women regardless of HPV DNA status at ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
the cobas 4800 HPV test (cobas). The panel comprises 1,300 stored samples that were obtained from women 25 to 64 years old who participated in the Slovenian cancer screening program, enriched with 300 ...
The use of the permanent sample (eps) to study the returnto- work after cancer. Challenges and opportunities for research
multidisciplinary consultation (MOC) in 2011. RESULTS: By the end of follow-up, 24 % of the workers were deceased. Among those who survived 26 % are unable to work, 12 % are unemployed and 63 % do not receive any ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
classified with cervical intraepithelial neoplasia (CIN) grade 2+ (CIN2 +) (n = 102) or CIN3 + (n = 55) within the previous 18 months. Controls were women who had normal cytology results over two subsequent ...